Granisetron reduces the incidence of nausea and vomiting after middle ear surgery

British Journal of Anaesthesia

Volumn 79, Issue 4, 1997, Pages 539-540

  Fujii, Y ^a   Toyooka, H ^a   Tanaka, H ^b  

^a UNIVERSITY OF TSUKUBA   (Japan)

^b Toride Kyodo General Hospital   (Japan)

Author keywords

Pharmacology, granisetron; Surgery, otolaryngological; Vomiting, antiemetics; Vomiting, nausea; Vomiting, nausea, surgical factors

Indexed keywords

ANTIEMETIC AGENT; GRANISETRON;

ADULT; AGED; ANESTHESIA INDUCTION; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; MIDDLE EAR SURGERY; NAUSEA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; VOMITING;

EID: 0030794819     PISSN: 00070912     EISSN: None     Source Type: Journal    
DOI: 10.1093/bja/79.4.539     Document Type: Article

References (8)

1. Honkavaara P, Saarinvaara L, Klemola U-K. Prevention of nausea and vomiting with transdermal hyocine in adults after middle ear surgery during general anaesthesia. British Journal of Anaesthesia 1994; 73: 763-766.
2. Reinhart DJ, Klein KW, Schroff E. Transdermal scopolamine for the reduction of postoperative nausea in outpatient ear surgery: a double-blind, randomized study. Anesthesia and Analgesia 1994; 79: 281-284.
3. Watcha MF, White PF. Postoperative nausea and vomiting. Its etiology, treatment, and prevention. Anesthesiology 1992; 77: 162-184.
4. 3 receptor antagonist. Anesthesia and Analgesia 1991; 72: 751-755.
5. 3 receptor antagonists the same? European Journal of Cancer 1992; 28: S2-6.
6. Honkavaara P. Effect of ondansetron on nausea and vomiting after middle ear surgery during general anaesthesia. British Journal of Anaesthesia 1996; 76: 316-318.
7. Fujii Y, Tanaka H, Toyooka H. Optimal anti-emetic doses of granisetron for preventing postoperative nausea and vomiting. Canadian Journal of Anaesthesia 1994; 41: 794-797.
8. 3 receptor antagonist: correlation of anti-emetic response. Cancer Chemotherapy and Pharmacology 1989; 24: 45-49.